Central nervous system |
133 |
Increases appetite and food intake |
|
Metabolic effects |
108 |
Increases blood glucose levels |
|
Stimulates fat deposit in adipose tissue
|
|
Growth hormone secretion |
95 |
More potent growth hormone* releaser than GHRH |
|
Endocrine pancreas. |
60 |
Relation to insulin* secretion is unclear and may depend on plasma glucose level |
|
Increases somatostatin* and PP* secretion |
|
Hypothalamic factors other than growth hormone |
46 |
High doses also release ACTH, prolactin, cortisol |
|
Affects gonadotroph secretion |
|
Cardiovascular physiology |
26 |
Decreases blood pressure |
|
Increases cardiac output and stroke volume |
|
Improves cardiac performance also when dysfunction is present |
|
Digestive system |
19 |
Increases gastric acid secretion |
|
Accelerates gastric emptying |
|
Offers gastroprotection against ulcerogens |
|
Reproductive physiology* |
15 |
Possible link between energy status and fertility |
|
Dose dependent inhibition or stimulation of cell proliferation of tumour cell lines. |
14 |
Central nervous system (other than appetite) |
9 |
Enhances anxiety
|
|
Increases memory retention |
|
Promotes slow wave sleep
|
|